CL2019002099A1 - Resistencia a la enfermedad de hsmi en salmonidos. - Google Patents

Resistencia a la enfermedad de hsmi en salmonidos.

Info

Publication number
CL2019002099A1
CL2019002099A1 CL2019002099A CL2019002099A CL2019002099A1 CL 2019002099 A1 CL2019002099 A1 CL 2019002099A1 CL 2019002099 A CL2019002099 A CL 2019002099A CL 2019002099 A CL2019002099 A CL 2019002099A CL 2019002099 A1 CL2019002099 A1 CL 2019002099A1
Authority
CL
Chile
Prior art keywords
salmonid
resistance
heart
inflammation
skeletal muscle
Prior art date
Application number
CL2019002099A
Other languages
English (en)
Inventor
Torgersen Jacob
Bruheim Torkjel
Evenstad Emilsen Vibeke
Moen Thomas
Santi Nina
Original Assignee
Aquagen As
James Mckay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aquagen As, James Mckay filed Critical Aquagen As
Publication of CL2019002099A1 publication Critical patent/CL2019002099A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/124Animal traits, i.e. production traits, including athletic performance or the like
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81Aquaculture, e.g. of fish

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Environmental Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)

Abstract

LA PRESENTE PATENTE ESTÁ RELACIONADA A LOS MÉTODOS DE PREDICCIÓN DE LA RESISTENCIA A LA INFLAMACIÓN DEL CORAZÓN Y DEL MÚSCULO ESQUELÉTICO EN SALMÓNIDOS, EL MÉTODO COMPRENDE DETERMINAR LOS ALELOS PRESENTES EN UN POLIMORFISMO DE ADN EN EL SALMÓNIDO Y PREDECIR SI EL SALMÓNIDO ES RESISTENTE O NO A LA INFLAMACIÓN DEL CORAZÓN Y DEL MÚSCULO ESQUELÉTICO BASADO EN LA DETERMINACIÓN DE LOS ALELOS. LA INVENCIÓN TAMBIÉN ESTÁ RELACIONADA A LOS MÉTODOS DE DETECCIÓN, EN UNA MUESTRA DE UN SALMÓNIDO, DE LOS ALELOS PRESENTES EN UN POLIMORFISMO DE ADN ASOCIADOS CON LA RESISTENCIA A LA INFLAMACIÓN DEL CORAZÓN Y DEL MÚSCULO ESQUELÉTICO, MÉTODOS PARA OBTENER UNA INDICACIÓN DE RIESGO DE QUE UN SALMÓNIDO DESARROLLE INFLAMACIÓN DEL CORAZÓN Y DEL MÚSCULO ESQUELÉTICO, USOS DE TALES POLIMORFISMOS DE ADN, Y MÉTODOS DE DETECCIÓN, EN UNA MUESTRA DE UN SALMÓNIDO, DE UNA O MÁS VARIANTES DE GENES SALMÓNIDOS.
CL2019002099A 2017-01-30 2019-07-26 Resistencia a la enfermedad de hsmi en salmonidos. CL2019002099A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1701480.4A GB201701480D0 (en) 2017-01-30 2017-01-30 Disease resistance

Publications (1)

Publication Number Publication Date
CL2019002099A1 true CL2019002099A1 (es) 2019-11-08

Family

ID=58462725

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019002099A CL2019002099A1 (es) 2017-01-30 2019-07-26 Resistencia a la enfermedad de hsmi en salmonidos.

Country Status (7)

Country Link
US (1) US11603564B2 (es)
EP (1) EP3574118B1 (es)
CA (1) CA3051798A1 (es)
CL (1) CL2019002099A1 (es)
DK (1) DK180777B1 (es)
GB (1) GB201701480D0 (es)
WO (1) WO2018138527A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO344967B1 (en) * 2019-01-30 2020-08-03 Patogen As Piscine Orthoreovirus Virulence Markers
US20210217488A1 (en) * 2020-01-09 2021-07-15 Cryoocyte, Inc. Fish farm material handling
NO346211B1 (en) * 2020-07-14 2022-04-19 Patogen As Piscine Orthoreovirus Virulence Markers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201212069D0 (en) * 2012-07-06 2012-08-22 Aqua Gen As Predicting resistance to disease
GB201400311D0 (en) 2014-01-08 2014-02-26 Aqua Gen As Treating Susceptibility
GB201400309D0 (en) 2014-01-08 2014-02-26 Aqua Gen As Predicting Resistance to disease

Also Published As

Publication number Publication date
US11603564B2 (en) 2023-03-14
EP3574118A1 (en) 2019-12-04
GB201701480D0 (en) 2017-03-15
WO2018138527A1 (en) 2018-08-02
EP3574118B1 (en) 2021-12-22
CA3051798A1 (en) 2018-08-02
DK201970480A1 (en) 2019-08-01
DK180777B1 (en) 2022-03-07
US20200190584A1 (en) 2020-06-18

Similar Documents

Publication Publication Date Title
CL2019002099A1 (es) Resistencia a la enfermedad de hsmi en salmonidos.
CO2018006301A2 (es) Mutantes de proteína f de rsv
BR112017002270A2 (pt) aptâmero, uso de um aptâmero, composição farmacêutica, coluna de aférese e método para a preparação de um oligonucleotídeo aptâmero
CL2017003069A1 (es) Métodos para diagnosticar y tratar el cáncer.
UY37594A (es) Biomarcador inmunologico para predecir el efecto clinico de inmunoterapia del cancer
MX2017006785A (es) Metodos y composiciones para radioetiquetado con 18f de productos biologicos.
BR112017025995A2 (pt) inibidor de igfbp3, composição farmacêutica para uso no tratamento e/ou prevenção de um distúrbio intestinal, método para o diagnóstico de um distúrbio intestinal em um indivíduo e kit para o diagnóstico de um distúrbio intestinal
MX2018000528A (es) Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.
CL2014001150A1 (es) Sistema y metodo donde el sistema particularmente es un dispositivo movil, para la determinacion de la concentracion de solutos en una muestra liquida coloreada, el cual se basa en la obtencion de imagenes de la muestra y de patrones de concentracion conocidos del soluto, y la determinacion de la concentracion de la muestra sobre la base del procesamiento de esas imagenes y los valores de color que las mismas proporcionan
BR112017003608A2 (pt) ?método para a análise comparativa do nível de expressão de mirna(s) alvo(s), dispositivo de análise da expressão de mirna, programa(s) para uma análise comparativa do(s) nível(eis) de expressão de mirna(s), meio de gravação legível por computador e chip para análise da expressão de mirna?
AR106422A1 (es) Análisis integrado de líquidos de poros para la caracterización potencial de los reservorios
AR099950A1 (es) Determinación de polimorfismos de un solo nucleótido de utilidad para la predicción de la respuesta a la rasagilina
CL2016003162A1 (es) Predicción de la capacidad del salmón atlántico para utilizar el pigmento dietético basado en la determinación de los polimorfismos.
CL2021001992A1 (es) Marcadores de virulencia de ortoreovirus de piscina.
CL2016001526A1 (es) Predicción de la resistencia a una infección viral.
BR112016028447A2 (pt) método para recuperar resina líquida bruta
BR112017009009A2 (pt) método e dispositivo para corrigir um ou mais níveis de expressão, programa(s) para a correção do(s) nível(eis) de expressão de rna(s), meio de gravação legível por computador e chip para análise da expressão de rna pequeno
AR102355A1 (es) Determinación de analitos en la matriz de muestra por extracción de solvente
AR110065A1 (es) Método de diagnóstico in vitro de la enfermedad de alzheimer basado en el nivel redox de la albúmina en el líquido cefalorraquídeo
Dourado et al. Knowledge and applicability of Nursing theories by undergraduate students
PL408305A1 (pl) Zastosowanie ceramidu C16 (C16-Cer) jako biomarkera w predykcji porodu przedwczesnego
WO2014068092A3 (de) Verfahren zur geschlechtsunabhängigen bestimmung von alterung
EA201491419A1 (ru) Косметический способ
ES2518715B1 (es) Método y kit para la detección de secuencias de ADN específicas de Mycobacterium tuberculosis complex en muestras pulmonares
Velibor et al. CHANGES OF DANCERS'FUNCTIONAL ABILITIES UNDER THE INFLUENCE OF PROPRIOCEPTIVE TRAINING AND TRAINING WITH A JUMP ROPE